Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Claim extract · Listening Library · media literacy

Miracle / single-session titles: media claim literacy

LAST REVIEWED 2026-09-22 · MEDIA OVERCLAIM RISK · HIGH-CONFIDENCE LL ENTRIES

Two Listening Library landmarks whose titles alone encode efficacy overclaim (and, in one case, lethal-risk acknowledgement). Extracted here as teaching examples for journalists and readers — not as endorsements and not as clinical guidance.

Media overclaim risk Miracle language refused Link-out only

Listening Library sources (outbound)

Related media-title risk (medium confidence, not the primary extract): mark-hyman-ibogaine-science-2025 (“One Dose That Heals…”).

Testable / checkable claims from titles

  1. “Miracle treatment” for PTSD and addiction.
    Verdict: Miracle language is not IbogaBase voice. PTSD evidence remains observational / limited — PTSD. Addiction cure language is overstated — cure check + OUD.
  2. “Stops opioid addiction in a single session.”
    Verdict: Overclaim relative to denominators, follow-up, and relapse uncertainty on the OUD desk. Title-level efficacy claims are not peer-reviewed results.
  3. Implicit or explicit lethal / cardiac risk in the same breath as efficacy.
    Literacy win: Risk acknowledgement is directionally compatible with QTc and mortality denominators — without converting podcasts into dosing manuals.

Adjacent observatory (not a miracle claim)

2026-09-21 TMZ quotes Bryan Hubbard rejecting miracle-cure framing amid Gerber cardiac-arrest news context — observatory only: TMZ / Hubbard card.

Verdict

Title-level miracle / single-session cure framing = media overclaim risk. Catalog for literacy; route readers to evidence grades and safety desks. No clinic referrals. No dosing.

Continue reading